The two are inextricably linked through a biological pathway known as the GH/IGF-1 axis
So, to find a solution to help these patients is an important issue, he added
If weight management is your goal, Wegovy or Mounjaro (tirzepatide) are the appropriate, licensed options in the UK
3h, i and Extended Data Fig
Related Read: 14 Peptides Are About to Become Legal Again What This Means for Your Health What the science says about peptide stacking as a category 1) Combination trials are the exception, not the rule For many popular peptides, we have: mechanistic arguments small studies (sometimes in narrow contexts) preclinical work We rarely have: well-powered, long-term human trials on the combination hard outcomes (function, cardiometabolic endpoints, durability, safety) 2) Stacking amplifies the two biggest risks in this space Quality risk (variable purity, contamination, labeling issues) Physiology risk (more pathways affected, more unintended effects) 3) The GH/IGF-1 axis is where stacking gets most clinically delicate CJC-1295 has human data showing it raises GH/IGF-1
From lifestyle changes and dietary improvements to cutting-edge medications like retatrutide and innovative peptides like MOTS-c , we now have more options than ever to tackle visceral fat effectively
